CESPHN is transitioning from Pen CS (CAT4) to Outcome Health (POLAR) for its funded general practice clinical audit tool
Central and Eastern Sydney Primary (CESPHN) is transitioning from Pen CS (CAT4) to Outcome Health (POLAR) for its funded general practice clinical audit tool
Central and Eastern Sydney PHN will be transitioning from PenCS’ CAT4 to Outcome Health’s POLAR GP data extraction tool over the next 2 months.
After a comprehensive review of our data collection pathways POLAR (Population Level Analysis and Reporting) was selected to ensure general practices can more efficiently share data for the PIP QI incentive and better meet quality improvement goals.
What is POLAR?
POLAR is a widely used web-based business intelligence tool for general practice. This tool extracts data from your practice software to help practices deliver better patient-centred care through meaningful data insights. [Learn more about the benefits of POLAR and POLAR Data Privacy and Security]
Why the change?
POLAR offers a modern, user friendly interface and advanced tools for data analysis and reporting that is better able to meet the needs of general practice.
Cost: POLAR will be 100% subsidised by CESPHN, with no direct or ongoing costs to practices. CESPHN and Outcome Health will work closely with you to ensure a seamless transition by 31 October 2025, in line with the start of the new PIP QI quarter on 1 November 2025.
What practices using Pen CS need to do
From early September, the Digital Health team will be contacting practices currently sharing data with CESPHN to:
Consult practices and explain the change
Provide an updated Data Management Agreement (DMA) – You will receive an email via Docusign for electronic signing by an authorised person and a witness
Install the POLAR software – Once the DMA is signed, a Digital Health Officer will arrange installation at a time convenient to your practice. Installation is quick and can be supported remotely by Outcome Health.
Immunisation Weekly Update: Change of process to order nirsevimab 50mg Order resources for childhood immunisation AIR updated to support pneumococcal program changes Education Change of process to order nirsevimab 50mg From 5 September, GPs will not be required to use the ‘nirsevimab order form’ on the NSW State Vaccine Centre…
Immunisation Weekly Update: Updated NSW Immunisation Schedule Updated pneumococcal resources Measles alert for Sydney Mpox clinician alert Minor facelift for Handbook Catch-up Calculator Education Updated NSW Immunisation Schedule The NSW Immunisation Schedule has been updated, with the following key changes that reflect updates to the childhood schedule and aim to…
Immunisation Weekly Update: Scholarship opportunity: 2025 Immunisation Professional Development Seminar Enhancements to the Australian Immunisation Register (AIR) – August 2025 Maternal RSV vaccine uptake continues to rise following inclusion on NIP New Aboriginal-led immunisation education toolkit Education Scholarship opportunity: 2025 Immunisation Professional Development Seminar Central and Eastern Sydney PHN is…
Immunisation Weekly Update: Prevenar 20 now available for order on SVC Influenza in children: not too late to vaccinate Scholarship opportunity: 2025 Immunisation Professional Development Seminar New mandatory AIR antenatal reporting requirements New adolescent vaccination SKAI resources Abrysvo RSV vaccine safe for co-administration in pregnancy Education Prevenar 20 now available…
Immunisation Weekly Update: Childhood pneumococcal vaccine schedule change ATAGI statement on RSV administration errors New National Guidelines for Yellow Fever Education Childhood pneumococcal vaccine schedule change Updated NIP childhood pneumococcal schedule The Department of Health, Disability and Ageing (DoHDA) has announced changes to the National Immunisation Program (NIP) childhood pneumococcal…